Evidence map›Paper›PMID 34718610›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2022

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia.

Prapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, Amélie Bonnefond, Serena Pezzilli, Tommaso Biagini, Patinut Buranasupkajorn, Timothy Hastings, Christine Mendonca, Lorella Marselli and 16 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 6 countries.

Prapaporn Jungtrakoon ThamtaranaResearch Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, USA.
Antonella MarucciResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Luca PannoneGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Amélie BonnefondInserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille, France.
Serena PezzilliResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Tommaso BiaginiUnit of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Patinut BuranasupkajornResearch Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, USA.
Timothy HastingsResearch Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, USA.
Christine MendoncaResearch Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, USA.
Lorella MarselliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Rosa Di PaolaResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Zuroida AbubakarCellular and Molecular Biology of Diabetes Research Group, Siriraj Center of Research Excellence for Diabetes and Obesity, Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Luana MercuriResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Federica AlbericoResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Elisabetta FlexDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Julian CerònModeling human diseases in C. elegans. Genes, Diseases and Therapies Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Montserrat Porta-de-la-RivaModeling human diseases in C. elegans. Genes, Diseases and Therapies Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Ornella LudovicoDepartment of Clinical Sciences, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Massimo CarellaResearch Unit of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Simone MartinelliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-5843-419X
Piero MarchettiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Tommaso MazzaUnit of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.
Philippe FroguelInserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille, France.
Vincenzo TrischittaResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Alessandro DoriaResearch Division, Joslin Diabetes Center, and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3830-4304
Sabrina PrudenteResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo,Italy.ORCID 0000-0001-9220-8981
Casa Sollievo della Sofferenza · ITJoslin Diabetes Center · USCentre National de la Recherche Scientifique · FRInstitut d'Investigació Biomédica de Bellvitge · ESIstituto Superiore di Sanità · ITUniversity of Pisa · ITBambino Gesù Children's Hospital · ITSiriraj Hospital · TH

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Search for new MODY genes and molecular studies of their function in beta cellsR01DK055523 · NIDDK · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO, KULKARNI, ROHIT N. · 1998 to 2014
$4.0M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK055523NIH HHS P40 OD010440NIH HHS R01DK55523
6 · The paper itself

Abstract

contextGenes causing familial forms of diabetes mellitus are only partially known.

objectiveWe set out to identify the genetic cause of hyperglycemia in multigenerational families with an apparent autosomal dominant form of adult-onset diabetes not due to mutations in known monogenic diabetes genes.

methodsExisting whole-exome sequencing (WES) data were used to identify exonic variants segregating with diabetes in 60 families from the United States and Italy. Functional studies were carried out in vitro (transduced MIN6-K8 cells) and in vivo (Caenorhabditis elegans) to assess the diabetogenic potential of 2 variants in the malate dehydrogenase 2 (MDH2) gene linked with hyperglycemia in 2 of the families.

resultsA very rare mutation (p.Arg52Cys) in MDH2 strongly segregated with hyperglycemia in 1 family from the United States. An infrequent MDH2 missense variant (p.Val160Met) also showed disease cosegregation in a family from Italy, although with reduced penetrance. In silico, both Arg52Cys and Val160Met were shown to affect MDH2 protein structure and function. In transfected HepG2 cells, both variants significantly increased MDH2 enzymatic activity, thereby decreasing the NAD+/NADH ratio-a change known to affect insulin signaling and secretion. Stable expression of human wild-type MDH2 in MIN6-K8 cell lines enhanced glucose- and GLP-1-stimulated insulin secretion. This effect was blunted by the Cys52 or Met160 substitutions. Nematodes carrying equivalent changes at the orthologous positions of the mdh-2 gene showed impaired glucose-stimulated insulin secretion.

conclusionOur findings suggest a central role of MDH2 in human glucose homeostasis and indicate that gain of function variants in this gene may be involved in the etiology of familial forms of diabetes.

Indexed as

AdultAgedAged, 80 and overAnimalsAnimals, Genetically ModifiedBlood GlucoseCaenorhabditis elegansCaenorhabditis elegans ProteinsCase-Control StudiesCell Line, TumorDNA Mutational AnalysisExome SequencingFemaleGain of Function MutationHumansHyperglycemiaBlood GlucoseCaenorhabditis elegans ProteinsInsulinMalate DehydrogenaseMDH2 protein, humanRecombinant Proteinsautosomal dominant diabetesgene mutationglucose homeostasisinsulin secretionKrebs cyclemonogenic diabetes

Identifiers

PMID34718610
PMCPMC8852227
OpenAlexW3209299419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.